Fetal thrombotic vasculopathy in the placenta: A thrombophilic connection between pregnancy complications and neonatal thrombosis?

Placenta

Volumn 25, Issue SUPPL. A, 2004, Pages

  Leistra Leistra, M J ^a   Timmer, A ^a   van Spronsen, F J ^a   Geven, W B ^a   van der Meer, J ^a   Erwich, J J H M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETAL THROMBOTIC VASCULOPATHY; FETUS DISEASE; HIGH RISK PREGNANCY; HOSPITAL INFORMATION SYSTEM; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; PLACENTA; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOPHILIA; THROMBOSIS;

EID: 1942423165     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2004.01.010     Document Type: Article

References (25)

1. Schmidt B, Andrew M. Neonatal thrombosis: a report of a prospective Canadian and international registry. Pediatrics 1995;96:939-43.
2. Nowak-Gottl U, Dübbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter related thrombosis in childhood: a prospective study. J Pediatr 1997; 131:608-12.
3. Chalmers EA. Neonatal thrombosis. J Clin Pathol 2000;53:419-23.
4. Andrew M, Monagle PT, Brooker L. Thromboembolic complications during infancy and childhood. Toronto (Canada): University of Toronto Press, 2000 ISBN 1-550-09036-4. 429 pp.
5. Nowak-Gottl U, Kries von R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-7.
6. Manco-Johnson M, Sifontes M, Nuss R, Hunger S, Loutzenhiser J, Jacobson L et al. Abstract: Coagulation abnormalities in neonatal catheter related thrombosis. Thromb Haemost 1999;82(suppl):384.
7. Ehrenforth S, Junker R, Koch HG, Kreuz W, Munchow N, Scharrer I et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Eur J Pediatr 1999;158(suppl 3): 97-104.
8. Munchow N, Kosch A, Schobess R, Junker R, Auberger K, Nowak-Göttl U. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis. Eur J Pediatr 1999;158(suppl 3):109-12.
9. Heller C, Schobess R, Kurnik K, Junker R, Gunther G, Kreuz W et al. Abdominal venous thrombosis in neonates and infants: a role of prothrombotic risk factors - a multicentre case-control study. Br J Haematol 2000;111:534-9.
10. Williams MD, Chalmers EA, Gibson BE. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002;119:295-309.
11. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child 1999;81:176-8.
12. Kosch A, Junker R, Kurnik K, Schobess R, Gunther G, Koch H et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents - a family study. Thromb Res 2000;99:531-7.
13. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000;96:45-9.
14. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000;53:573-80.
15. Sibai BM. Thrombophilias and adverse outcomes of pregnancy - What should a clinician do? N Engl J Med 1999;340:50-1.
16. Nelson-Piercy C. Inherited thrombophilia and adverse pregnancy outcome: has the time come for selective testing? Br J Obstet Gynaecol 1999; 106:513-5.
17. Greer IA. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 2000;342:424-5.
18. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995;26:80-5.
19. Kraus T, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol 1999;30:759-69.
20. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000; 15:1830-3.
21. Sikkema JM, Franx A, Bruinse HW, Wijk van der N, Valk de HW, Nikkels PGJ. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 2002;23:337-42.
22. Van der Molen EF, Verbruggen B, Novakova I, Eskes TK, Monnens LA, Blom HJ. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol 2000;182:1258-63.
23. Khong TY, Hague WM. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol 1999;106:273-8.
24. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-5.
25. Khong TY, Hague WM. Biparental contribution to fetal thrombophilia in discordant twin intrauterine growth restriction. Am J Obstet Gynecol 2001;185:244-5.